Inhibitory effect of glucocorticosteroids on anti-IgE-induced histamine release from human basophilic leukocytes: evidence for a dual mechanism of action.
Anti-IgE-induced histamine release from human leukocytes is inhibited when the cells before challenge are cultured overnight in the presence of glucocorticoids (GCSs). The present report suggests that the GCSs might exert their effect by at least a dual mechanism of action. Histamine release was induced by a suboptimum concentration of anti-IgE. When the release recorded in the presence of the steroid is plotted against the release recorded in its absence, the data points of several experiments fit a regression line characterized by two parameters: its slope and its intercept with the abscissa. Structure-activity examination with selected GCSs indicates that the orders of potency for affecting these two parameters are not identical. Furthermore, pulse experiments suggest that the cells require different times of contact with the steroid to express inhibition according to the two parameters. The removal of adherent cells or platelets did not markedly affect the degree of leukocyte histamine release or its inhibition by a given GCS, suggesting that the steroid interacts directly with the basophil. Finally, steroid-induced inhibition was not affected by the putative phospholipase A2-inhibitor p-bromophenacylbromide (BPB) or the 5-lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA).
D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D001491:Basophils / Q000378:metabolism*; D001623:Betamethasone / Q000494:pharmacology; D019819:Budesonide; D002448:Cell Adhesion; D003350:Cortodoxone / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005448:Fluocortolone / Q000031:analogs & derivatives / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology*; D006636:Histamine Release; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D011282:Pregnenediones / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011736:Pyridoxine / Q000494:pharmacology; D013997:Time Factors
D000888:Antibodies, Anti-Idiotypic; D005938:Glucocorticoids; D011282:Pregnenediones; D007073:Immunoglobulin E; D003900:Desoxycorticosterone; D019819:Budesonide; D005448:Fluocortolone; C011824:fluocortin butyl ester; D003907:Dexamethasone; D001623:Betamethasone; D011736:Pyridoxine; D003350:Cortodoxone